Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-finding study of K-877 in combination with pitavastatin
jRCT2080221795Phase 3
- Sponsor
- Kowa Company, Ltd.
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in dyslipidemia, hypertriglyceridemia and hyperlipidemia comparing K-877 + pitavastatin with Placebo + pitavastatin (2 arms).
02
Drugs
pemafibrate
03
Conditions
dyslipidemiahypertriglyceridemiahyperlipidemia
Beyond the preview
Go deeper on jRCT2080221795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221795.